SHUR IQ • Intelligence Briefing • Investor Read

Two founders named a category. The question is whether they can keep it.

Smearcase commercialized and named the frozen cottage cheese pint — “FroCo” — and rides a verified $2 billion cottage-cheese surge into a freezer set migrating toward better-for-you protein. It is raising a $1.25M seed at a $6.75M cap (company-stated) on $336k of trailing revenue. That price is a bet on category creation — the cap sits far ahead of today’s ~$336k of trailing revenue, riding on whether a two-person company defends the chair it named before a better-capitalized neighbor takes it.

Smearcase — Frozen Cottage Cheese (“FroCo”) Editorial Brief — v01 A Portfolio Investor Read Shur Creative Partners — May 2026

Open the interactive Viz Hub — five viewports

$6.75M / $336k

Seed cap against trailing revenue — the bet itself (company-stated)

$2B+ · +19.2%

US cottage cheese sales in 2025 — the verified tailwind

~$500M

The reported Good Culture deal — the exit ceiling, and the threat

47 / 100

Structural-advantage score — held back by the broken edge

Letter from the Editor II

Three verified forces converge on one freezer shelf in 2026, and a fourth sets the ceiling. Seventy percent of consumers are actively trying to eat more protein, up from sixty-two percent in 2021.^[8] US cottage cheese sales topped two billion dollars in 2025, up 19.2 percent after four straight years of acceleration.^[4] Demand is migrating to the better-for-you freezer set in real time — “lighter alternatives” jumped twenty-nine percent in 2025 while traditional ice cream dipped. And L Catterton’s reported five-hundred-million-dollar Good Culture deal proves a strategic buyer will pay a premium in this exact base category.^[3] Smearcase sits where those forces meet. The same forces that validate the demand are the invitation to the giants who can copy a recipe and a name. This brief is timely because the category Smearcase named is becoming valuable while the question of who defends it is still open.

The brief does not score Smearcase’s marketing. It reads the shape of the conversation: what the category talks about, who gets named, where the brand’s loudest claim and its most durable signals sit apart, which room the public has already filed the brand into. The findings are structural. The Value-Creation Levers are founder-actionable and investor-legible. The score is a relative position — against the protein-ice-cream pint set and against the moment — not a performance metric. It measures durable structural advantage, not this quarter’s sales.

The Reframe is one reading. The brief is the start of a conversation, not its conclusion. The Bridge names the question the brief leaves open — whether “FroCo” is a defensible category or a copyable feature. The watch-items make the next 30 days concrete: the sell-through read, the defensibility audit, the pinned category framing. If diligence reveals the January spike was repeatable velocity, the bet strengthens on its own terms; if it was channel fill, the broken edge stays broken and the timing watch against the giants becomes the whole story. Either way, the investor reads the round from the earned layer, and the watch-items are priced.

The cap prices category creation, not traction. A $6.75M cap on $336k of trailing revenue (both company-stated) is an underwrite of one question: does “FroCo” become a defensible shelf set, and can a two-person company defend it before a giant takes it?
The earned signals are stronger than the self-claims. A first institutional check from Listen Ventures, three competition wins (two inside ninety days, one a cash prize), and trade press adopting the category name are the durable layer — discount the company-asserted $2M run-rate, which annualizes a single spike month.
Smearcase is the empty chair between the category’s two best future owners. The brand with cottage-cheese authority (Good Culture) and the major with freezer power (The Magnum Ice Cream Company via Yasso) sit in separate rooms. Smearcase is the only brand speaking both languages — alone, and copyable.
One weakness is read twice. The two lowest structural scores, distribution and capital, share a single cause: a two-person company that has not yet raised the round to buy shelf velocity. The round being raised is the bridge — and the January spike is the test of whether it converts.

— ShurIQ, Shur Creative Partners

Smearcase’s $6.75M cap on $336k of trailing revenue is a bet on category creation, not on current traction. The investor is underwriting one question: does “FroCo” — frozen cottage cheese — become a defensible shelf set that Smearcase commercialized and named first, and can the brand reach a strategic-buyer relationship before Good Culture, The Magnum Ice Cream Company, or private label ships a cottage-cheese pint of its own? The thing to watch is the earned layer — a first institutional check, three competition wins, the trade press adopting the category name — not the run-rate.

The Reframe — Shur Creative Partners

The Reframe — Why this is the hinge III

The Reframe moves the frame the deck works inside and relocates it to the frame that decides the outcome. The deck’s frame is true and incomplete: Smearcase is a fast-scaling, proven brand with a $2M run-rate. The frame that determines the result is the one a diligence-minded investor is already forming: the cap prices a category-creation option, and the soft self-claims should be discounted in favor of the durable earned signals.

The deck’s loudest numbers are the softest under scrutiny. The company-asserted $2M run-rate annualizes a single ~$175k month against prior months mostly under $40k; a 60g protein figure is unsupported, with a verified ceiling of 44g.^[2]^[7] The quietest facts are the durable ones: a first institutional check from Listen Ventures, three competition wins, and trade press adopting “FroCo.”^[5]^[6] The brief leads with the affirmative bet — a named and currently unoccupied chair in a growing category — and re-roots every watch-item in the verified layer. One Reframe; the whole brief demonstrates the move and never derives toward it.

Numbers Spine — The evidence base IV

Eight anchors. The single source of truth for every numeric claim in the brief. Each is labelled company-asserted or verified; subsequent sections reference these values without re-citing them as if independently sourced.

[1]	$6.75M / $336k	Seed SAFE valuation cap against trailing-twelve-month revenue — roughly a 20× trailing-revenue cap. The bet itself: a price on category creation, not on current traction.^[1] Company-asserted
[2]	$2M run-rate	The deck’s headline traction number, annualized from a single January 2026 spike (~$175k) against prior months mostly under $40k. The first watch-item: channel fill (sell-in) or repeatable demand (sell-through).^[2] Company-asserted
[3]	~$500M	Reported L Catterton majority-stake deal valuing Good Culture (announced Jan 2026, close Q1). The exit ceiling, held as a category-appetite signal — not an implied Smearcase valuation (a ~700× revenue gap separates the two).^[3] Verified
[4]	$2B+ · +19.2%	US cottage cheese sales in 2025, up 19.2% in dollars after four straight years of acceleration. The measured tailwind the FroCo wedge rides.^[4] Verified
[5]	Three wins	Real California Milk Excelerator Grand Prize ($100k in-kind marketing, Dec 2025); Albertsons Innovation Launchpad first place (Mar 2026; the prize pool across all three winners exceeded $400k in combined cash and services); Conscious Beauty & Wellness Pitch ($10k cash, the only verified cash prize). Buyer-side validation competitors cannot self-assert; two within ~90 days.^[5] Verified
[6]	Listen Ventures	First institutional investor (Chicago; amount undisclosed). The verified anchor of the round — the durable signal under the SAFE.^[6] Verified
[7]	40–44g protein	The headline product claim, per pint (company packaging; third-party press reports 39–44g; Peanut Butter at 44g is the line ceiling). The deck’s 60g Mocha Joe figure is unsupported and dropped.^[7] Company packaging + verified press
[8]	70% · +29%	Consumers actively trying to eat more protein (up from 62% in 2021) / the 2025 jump in “lighter alternatives” while traditional ice cream dipped. The macro shortcut and the demand migrating onto Smearcase’s exact shelf.^[8] Verified

Structural Gaps — Five named breaks V

Five gaps read from the public conversation. Each names two rooms that should connect and currently do not. The connection is the diagnosis; the prose under each card is the consequence; the bridging concept is the move that closes it.

See the gaps in motion — Gap Radar

Competitive Lens — The seven-brand view VI

The cohort is the protein-ice-cream pint set — the shelf Smearcase actually competes on. The cottage-cheese wave is modeled as the tailwind-and-threat axis (Gaps 2 and 4), not head-to-head. Seven brands, scored across five dimensions of durable structural advantage, each 0–100, ranked by composite.

#	Brand	Owner / stage	Product	Category Own.	Distribution	Community	Capital	Composite	Tier
1	Yasso	The Magnum Ice Cream Company	70	68	92	74	90	78	Strong Ecosystem Player
2	Two Good	Danone	66	70	90	70	88	74	Strong Ecosystem Player
3	Halo Top	Ferrero (via Wells)	58	82	78	60	70	68	Emerging Power (declining)
4	Nick’s	Founder-led, Series C (2021)	68	58	60	56	72	61	Emerging Power
5	Two Spoons	Founder-led, early	64	52	38	46	44	49	Niche Player
6	Smearcase	Founder-led, seed	62	64	36	50	30	47	Niche Player
7	Enlightened	Beyond Better Foods (dormant)	50	40	30	36	30	38	Limited Structural Presence

■ Distribution and Capital for Smearcase — the broken edge: the two lowest dimensions, low for one shared reason, and the ones capital is meant to lift.

See what is missing — The Space Between

Structural Brand Power Index VII

A structural-advantage score: how defensible a place on the shelf is, not this quarter’s sales — rated 0 to 100 across five dimensions, each split evenly between what the brand holds today and the room it has to climb.

Scale caveat — four of the seven brands in the set are owned by or were sold to global food companies. Their distribution and capital scores reflect corporate capacity, not category commitment. Smearcase’s low scores on those two dimensions reflect stage, not strategy. Both are buyable. The bet is whether Smearcase buys them in time.

Product Strength 62.0 / 100

A genuinely differentiated cottage-cheese-based formulation, clean label (no seed oils, real sugar, no sugar alcohols), 40–44g protein per pint (company packaging; third-party press reports 39–44g), and the highest claimed nutrition score in the set (a company-cited Yuka 78, pending an independent re-pull). The drag: a known texture gap (a Delish review flags graininess), cane sugar sitting on the wrong side of the fastest-growing claim axis (zero-added-sugar, GLP-1-friendly), and the scoped collagen compliance question. Present is 54 because the product genuinely differentiates; Opportunity is 70 because a texture and claim refinement is achievable.

Category Ownership 64.0 / 100

First to commercialize and name the frozen-cottage-cheese pint (company-asserted, plausible, uncontested); the “FroCo” coinage is being adopted by trade press (Mintel, NOSH, Dairy Foods); public search already files the brand under cottage cheese. This is Smearcase’s highest score and the dimension the whole bet rests on. The drag: the name is copyable, and the most credible future owner of the category sits one room away with ~700× the revenue and ~$500M of fresh capital. Present is 58 because ownership is genuinely claimed; Opportunity is 70 because it is not yet defended.

Distribution Power 36.0 / 100

Real placements (Whole Foods, Sprouts) and credible distributor relationships (UNFI, KeHE), with a forward path to 1,000+ doors by Q2 2026. The drag: door count is “available in,” not “winning velocity in”; the central unknown is sell-in versus sell-through; there is no freezer-slot ownership and only ~34K combined social reach. Present is 28 because availability is not velocity; Opportunity is 44 because this is the lowest-leverage room and the one capital is meant to fix. The lowest dimension by leverage weight (25%).

Community & Demand 50.0 / 100

The earned-signal stack competitors cannot self-assert: a first institutional check (Listen Ventures), three competition wins (two within ~90 days, one a $10k cash prize), deep trade press, a Delish review, and a men’s-health/fitness roundup of the 15 best high-protein products (Men’s Hub, menshb.com). The drag: demand pull is buyer-led, not consumer-led; repeat-purchase signal is unproven; the social audience is thin for the run-rate the deck claims. Present is 44 because the earned validation is real; Opportunity is 56 because consumer pull is unbuilt.

Capital & Monetization 30.0 / 100

A $1.25M seed SAFE in progress at a $6.75M cap (deck-stated; no filing surfaced); a $10k verified cash prize; two large prizes that are in-kind or mixed, not deployable cash. The drag: two founders plus one contractor against a 1,000-door target; margins unverifiable on public data (a named diligence gap); no balance-sheet depth versus a major. Present is 22 because the structural floor is real; Opportunity is 38 because the round being raised is the bridge. The structural floor of the index.

See dimensions in motion — Structural Advantage

Value-Creation Levers — Five moves that de-risk the bet VIII

Five levers, each closing a named Index dimension and framed as what creates enterprise value for the bet. Founder-actionable, read here as what a holder should want the company to do. Each carries three tags — Priority, Effort, and Impact — so the move can be sequenced against cost and urgency at a glance.

Sequencing Levers 01 and 02 are the unlock moves — lowest cost relative to impact, and they reset how the round reads in the next 30 days. Lever 03 is the category-defense work that runs across the quarter and protects the multiple. Levers 04 and 05 stack on top: the close funds the velocity bridge, and the compliance-and-product pass removes the diligence flag before scale.

What To Watch — The three signals that move the bet IX

Three things decide whether the bet pays. Each is a watch-item the investor cannot resolve from the deck, and each maps to a concrete diagnostic move.

What we ask in the next 30 days — access and one decision. A velocity read that resolves the run-rate, a named-moat audit on defensibility, and a pinned category framing with the margin gap turned into a diligence request. The score lifts from 47 to a projected 56 on the moves these unlock.

The Ask — Shur Creative Partners

The Ask — A 30-day positioning diagnostic IX

Bridge — The open question X

Is “FroCo” a defensible category Smearcase can own, or a copyable feature inside the protein-pint stack? This is the one question the brief cannot answer from the outside, and it is the question the cap encodes. The verified signals point in the encouraging direction — the trade press has adopted the term, and public search already files Smearcase under cottage cheese rather than the commodity shelf. The threat is equally real — the name is a recipe and a word, and the category’s most credible future owner sits one room away with ~$500M of capital. Both readings live in the same set of facts. The brief leaves this open because the answer depends on what Smearcase does next — whether it converts the naming claim into a held position before a neighbor sits down — and on data the investor will gather in diligence. The 30-day diagnostic surfaces which way it breaks. What is not optional is the watch: every quarter the chair goes undefended, the option decays.

Shur Creative Partners · May 2026

Appendix — Glossary, methodology, sources XI

Glossary

Reframe: A single conceptual move that shifts the frame inside which a question is asked. One Reframe per brief. The body demonstrates the move rather than deriving toward it.
Structural Brand Power Index: A composite 0–100 structural-advantage score — how defensible a position in a category is, not this quarter’s sales — across five dimensions weighted 20/20/25/20/15. Each dimension splits 50/50 between what is present today and the opportunity that is open. The broken edge is the dimension pair that shares one cause and lifts together.
Structural Gap: Two rooms in the public conversation that should connect and currently do not. Severity scored 1–10 by the size of the connecting topics and the strategic cost of the absence.
The Broken Edge: The pair of Index dimensions that share a single underlying cause, so that one move lifts both at once. For Smearcase, it is Distribution Power paired with Capital & Monetization — both resting on whether the round closes and buys shelf velocity.

Methodology

ShurIQ reads Smearcase from the outside. Public-web evidence — smearcase.com, the seed deck, trade press (NOSH, Dairy Foods, Mintel, Food Business News), award newsrooms (PR Newswire, Albertsons, New Hope), competitor marketing surfaces, and category data (Circana via CNN Business, Dairy Foods, Empower) — is combined with a structural reading of the public conversation: the brand’s own narrative, the competitive set’s merged narrative, and the category conversation across eight seeded search queries. The brief does not score Smearcase’s marketing or measure traffic; it reads the shape of the conversation. The findings are structural; the score is a relative position inside the protein-ice-cream pint set and against the moment. No transcripts, no interviews, no internal Smearcase data were used. Company-asserted claims (the deck and site) are kept separate from third-party-verified signals throughout, and no traction is inferred. Every numeric claim traces to the Numbers Spine and the Source Index. The technical terms behind the plain-English findings — the routing measures and conversation-separation values for the three maps built May 28, 2026 — are recorded in the project graph readout and are not reproduced in this brief.

Source Index

1	$1.25M seed SAFE at a $6.75M valuation cap on $336k TTM revenue — company-asserted; deck-stated, no Form D or third-party figure surfaced — Smearcase seed deck (March 2026) and smearcase.com
2	$2M run-rate annualized from a single ~$175k January 2026 month against prior months mostly under $40k — company-asserted; no third-party corroboration; the claimed 2026 target ($1.3M) sits below it — Smearcase seed deck
3	L Catterton reported majority stake valuing Good Culture at ~$500M (announced Jan 2026, close Q1); a category-appetite signal only, not an implied Smearcase valuation — CNN Business / Dairy Reporter
4	US cottage cheese sales topped $2B in 2025, up 19.2% in dollars after four straight years of acceleration — Circana via CNN Business / Dairy Foods
5	Three competition wins — Real California Milk Excelerator Grand Prize ($100k in-kind marketing, Dec 2025); Albertsons Innovation Launchpad first place (Mar 2026; prize pool >$400k combined cash + services across all three winners); Conscious Beauty & Wellness Pitch ($10k cash, the only verified cash prize) — PR Newswire, Albertsons newsroom, New Hope
6	Listen Ventures (Chicago) — first institutional investor; amount undisclosed — NOSH exclusive / Food Business News
7	40–44g protein per pint — company packaging; third-party press reports 39–44g (Peanut Butter 44g is the line ceiling); the deck’s 60g Mocha Joe figure is unsupported and dropped — stack3d, NOSH, Albertsons
8	70% of consumers actively trying to eat more protein (up from 62% in 2021) / the 2025 +29% jump in “lighter alternatives” while traditional ice cream dipped — Empower / Cargill 2025; market data 2025

Disclosure

This brief uses public-web evidence only; no internal Smearcase data, transcripts, or interviews were used. Company-asserted claims (the $2M run-rate, the $336k TTM, the $6.75M cap, the company-cited Yuka 78, and the company-packaging protein figure) are kept separate from third-party-verified signals throughout and are never presented as independent fact. The 60g protein figure is dropped; the brief cites 40–44g per pint only. The Albertsons prize is a combined pool exceeding $400k across three winners (cash and services), never a specific Smearcase cash figure; the RCM Grand Prize is in-kind marketing support. The ~$500M Good Culture comp is a category-appetite signal only — the ~700× revenue gap to Smearcase keeps any near-term Smearcase valuation inference off the table. “First to commercialize and name” the frozen-cottage-cheese pint is company-asserted, plausible, and uncontested; it is not stated as “world’s first” or “the only.” Margins are unverifiable on public data and framed as a named diligence gap. All numeric claims trace to the Numbers Spine and the Source Index above. The Reframe is a reading the diagnostic is designed to test; the Bridge surfaces the question whose answer redirects the editorial move.

Two founders named a category. The question is whether they can keep it.

The brand’s loudest number and its most durable assets never appear together.

The category’s two best future owners sit in separate rooms, and Smearcase is the empty chair between them.

The protein-pint shelf and the cottage-cheese category are two conversations, and which one Smearcase belongs in sets the multiple.

The tailwind that validates the demand is the same fact that invites the giants.

The brand’s entire identity is a protein number, and the protein carries a scoped compliance question the marketing never meets.

Product Strength 62.0 / 100

Category Ownership 64.0 / 100

Distribution Power 36.0 / 100

Community & Demand 50.0 / 100

Capital & Monetization 30.0 / 100

The Broken Edge

Recovery Move

Re-order the story: lead with the earned signals, discount the run-rate.

Resolve sell-in versus sell-through, and publish the velocity read.

Name and defend the chair before a neighbor sits down.

Close the round and deploy it as the velocity bridge.

Clear the headline claim’s compliance question and tighten the product edge.

A 30-day positioning diagnostic. Shur runs it. The founders provide access and one decision.

Glossary

Methodology

Source Index

Disclosure